Effect of protein product supplementation on sarcopenia in patients with acute stroke phase.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0006830

Enrollment

Registered

2021-12-10

Start date

2021-04-05

Completion date

Unknown

Last updated

2022-01-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Dietary Supplement : Subacute stroke patients who had stroke-related disabilities were enrolled and given dietary supplement powder containing BCAAs for 1 month. These BCAAs were as supplied through t

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Subacute stroke patients who had stroke-related disabilities such as paralysis and dysphagia, thus required intensive inpatient rehabilitation intervention were enrolled.

Exclusion criteria

Exclusion criteria: - Patients who had previous stroke history - Patients who had higher blood urea nitrogen and creatine levels, chronic kidney disease, - an uncontrolled infectious status were excluded from this study.

Design outcomes

Primary

Measure	Time frame
skeletal muscle index (SMI)	—

Secondary

Measure	Time frame
functional evaluations related to stroke	—

Countries

Korea, Republic of

Contacts

Public ContactSook Joung Lee

The Catholic University of Korea, Daejeon St. Mary's Hospital

lsj995414@hanmail.net+82-42-220-9650

Outcome results